Physical Therapists in Marion, KS Accepting Medicare
5 Physical Therapists found. Showing 1 - 5
 Jamee Renee Funk, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 535 S Freeborn St, Marion, KS 66861 Phone: 620-382-2863 |
Jennica Nadine O'neill, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 535 S Freeborn St, Marion, KS 66861 Phone: 620-382-2177 |
Mrs. Sheryl Jean Simmonds, LPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 535 S Freeborn St, Marion, KS 66861 Phone: 620-382-2863 |
 Xenophon Phillip Smith, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 302 Elm St, Marion, KS 66861 Phone: 620-382-2191 |
Jacob Simmonds Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 535 S Freeborn St, Marion, KS 66861 Phone: 620-382-2177 Fax: 620-382-9104 |
News Archive
MGH researchers discover how obesity increases inflammation, desmoplasia in PDAC patients
Massachusetts General Hospital investigators have discovered the mechanism by which obesity increases inflammation and desmoplasia - an accumulation of connective tissue - in the most common form of pancreatic cancer.
Cancer scientists confirm oligometastasis hypothesis
In 1995, two University of Chicago-based cancer specialists suggested there was an intermediate state -; somewhere between curable localized cancers and lethal widespread disease -; for patients with metastatic cancer.
Plain facts about health risks of sugary drinks may offer new strategy to reduce childhood obesity
A new study at Columbia University suggests that giving mothers plain facts about the health risks of consuming sugary drinks during pregnancy and early childhood may offer a new strategy to reduce childhood obesity.
Study highlights need for dedicated palliative care services to improve care quality
Findings from an international study into the costs and outcomes of informal end of life care have today been published BMC Medicine.
Takeda responds to FDA recommendation on Actos
Following a joint meeting today of the U.S. Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, Takeda Global Research & Development (TGRD) underscores its position that ACTOS(R) (pioglitazone HCl) offers a proven safety profile regarding the risk of cardiovascular disease.
› Verified 9 days ago
Chiropractors
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Optometrists